Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-05-29
2007-05-29
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S266220, C514S266230, C514S266240, C514S252170, C544S115000, C544S287000
Reexamination Certificate
active
10496460
ABSTRACT:
The invention concerns the use of the quinazoline derivatives of Formula (I) wherein each of m, R1, Z, n and R3have any of the meanings defined in the description in the manufacture of a medicament for use in the prevention or treatment of T cell mediated diseases or medical conditions in a warm-blooded animal
REFERENCES:
patent: 2004/0138240 (2004-07-01), Ple
patent: 0 607 439 (1994-07-01), None
patent: 607439 (1994-07-01), None
patent: 02/85895 (2002-10-01), None
Moore Nelly Corine
Oldham Keith
AstraZeneca AB
Grazier Nyeemah
Morgan & Lewis & Bockius, LLP
Saeed Kamal A.
LandOfFree
Quinazoline compounds with therapeutic use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinazoline compounds with therapeutic use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinazoline compounds with therapeutic use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3754918